# Fenretinide in Treating Patients With Recurrent Malignant Glioma

> **NCT00006080** · PHASE2 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins**

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** fenretinide

## Key facts

- **NCT ID:** NCT00006080
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09-25
- **Primary completion:** 2004-09-14
- **Final completion:** 2004-11-01
- **Target enrollment:** — (—)
- **Last updated:** 2018-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006080, "Fenretinide in Treating Patients With Recurrent Malignant Glioma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00006080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*